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Abstract
Background: Filoviruses, including Ebola virus, are unusual in being filamentous animal viruses. Structural data on the
arrangement, stoichiometry and organisation of the component molecules of filoviruses has until now been lacking,
partially due to the need to work under level 4 biological containment. The present study provides unique insights into the
structure of this deadly pathogen.
Methodology and Principal Findings: We have investigated the structure of Ebola virus using a combination of cryo-
electron microscopy, cryo-electron tomography, sub-tomogram averaging, and single particle image processing. Here we
report the three-dimensional structure and architecture of Ebola virus and establish that multiple copies of the RNA genome
can be packaged to produce polyploid virus particles, through an extreme degree of length polymorphism. We show that
the helical Ebola virus inner nucleocapsid containing RNA and nucleoprotein is stabilized by an outer layer of VP24-VP35
bridges. Elucidation of the structure of the membrane-associated glycoprotein in its native state indicates that the putative
receptor-binding site is occluded within the molecule, while a major neutralizing epitope is exposed on its surface proximal
to the viral envelope. The matrix protein VP40 forms a regular lattice within the envelope, although its contacts with the
nucleocapsid are irregular.
Conclusions: The results of this study demonstrate a modular organization in Ebola virus that accommodates a well-
ordered, symmetrical nucleocapsid within a flexible, tubular membrane envelope.
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Introduction
Viruses have evolved as genome packaging machines to
efficiently transfer nucleic acids between susceptible host cells,
ensuring replication. The majority of viruses have hollow, quasi-
spherical shells rather than tubular structures, perhaps because this
gives the most efficient packaging of nucleic acid with a fixed copy
number of coat protein subunits. In non-enveloped viruses, the
volume enclosed by the (usually) icosahedral structure is a
constraint on the size of the genome, giving a limited capacity to
encode capsid proteins, and usually restricts the genome copy
number, or ploidy of the virion, to one [1]. Most membrane-
enveloped viruses are also quasi-spherical, but their symmetry is
frequently less well-ordered, which is usually described as
pleomorphic. This feature allows some flexibility in volume,
which could accommodate variation in the size of the genome or
its copy number. Nevertheless, most viruses, irrespective of their
architecture, appear to have evolved to encapsidate only a single
copy of their genome within the protein or protein/lipid shell, or a
dimeric copy in retroviruses. Notable exceptions are the
Paramyxoviridae and the Birnaviridae where particles may contain
up to four copies of the RNA genomes [2,3]. Although some
strains of influenza can produce elongated virions, there is a
mechanism that selectively encapsidates only one set of genome
segments in each virion [4].
The Filoviridae family, including the Ebolavirus and Marburgvirus
genera, cause haemorrhagic fevers with high mortality in humans,
and no effective treatments are currently approved [5], although
candidate vaccines are promising [6]. The 18.9 kb single-stranded
negative-sense non-segmented RNA genome of Ebola virus
(EBOV) codes for at least eight proteins. The ribonucleoprotein
complex is composed of the nucleoprotein (NP), polymerase
protein (L), VP24, VP30, and VP35. The trimeric transmembrane
glycoprotein (GP) forms surface spikes on the virion envelope and
also has a soluble form, while the matrix protein, VP40, is
associated with the inner surface. [5,7–9]. The GP spike, a class I
fusion protein, mediates cellular attachment and entry and is
extensively glycosylated, especially in the glycan-rich mucin-like
domain [10–13]. Three proteins, VP24, VP35 and NP are
essential for nucleocapsid formation [14]. Although some of the
major protein interactions that occur during EBOV morphogen-
esis have been characterised [14,15] , the three-dimensional (3D)
structure and molecular arrangements have not been previously
determined. Structural details are essential to understand how
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are achieved in a filamentous animal virus, and to determine how
this unique morphology plays a role in pathogenesis.
Research on filoviruses has been hampered by their status as
biosafety level 4 pathogens. Previous investigations of filovirus
structures within embedded, sectioned and metal-stained cells by
electron tomography revealed few details of the high resolution
oligomeric structure [16,17]. It has been demonstrated that
aldehyde-fixation alone, and subsequent cryo-electron microscopic
imaging in the frozen-hydrated state preserves structures, at least
up to 12 angstroms resolution [18], and in some cases, fixation
improves the resolution achievable [19]. In addition, it has also
been shown that high-resolution X-ray structures can also be
obtained in the presence of aldehyde fixatives [20]. Therefore, we
analyzed purified and isolated EBOV and Ebola virus-like
structures using cryo-electron microscopy (cryo-EM), and cryo-
electron tomography (cryo-ET). In the current study, the Zaire
strain of EBOV was purified and inactivated by paraformaldehyde
fixation: excess fixative was then removed by dialysis to reduce
beam damage for imaging in the frozen-hydrated state. The flash-
freezing at liquid ethane temperatures used in cryo-electron
microscopy preserves the structural and molecular detail, avoiding
artifacts associated with conventional EM methods, such as
dehydration and/or sectioning or staining, that usually prevent
detailed structural analysis. Digital image processing reveals the
3D organization of EBOV, including the structural arrangement
of component molecules at resolutions of 14–19 A ˚.
Results and Discussion
Structure of EBOV
We identified filamentous EBOV particles 20 microns or longer,
with a well ordered internal structure, and a helical nucleocapsid
giving an internal ‘‘herring-bone’’ appearance using cryo-EM and
cryo-ET (Figures 1, 2, S1, S5). The nucleocapsid, as observed
within intact viral particles, has a uniform helical structure
(Figures 1, 2, 3, 4) and is enveloped by a membrane coated by an
external layer of GP spikes. From the same image data set, we
combined extracted volumes from tomograms with 2-D single
particle processing to determine the structure of the GP spikes
(Figure 5) to a resolution of 14 A ˚ as measured by the Fourier Shell
Correlation (FSC) 0.5 criterion. Virions are rarely straight.
Variation in the overall length of virions is non-random, and they
fit into ordered size classes (Figure 1). Analysis of 2090 distinct
intact virions with a nucleocapsid from cryo-electron micrographs
shows that the most common class length (53%) of virus particles is
982679 nm (Figure 1A, Table S1). The other size classes are
multiples of this length. Enveloped filovirus particles have several
Figure 1. Quantitation of Ebola virus length. (A) Histogram of virion length, with cryo-EM images showing single, continuous and linked
particles. A total of 2090 virions with continuous nucleocapsids (no obvious segmentations) were measured, showing the relationship between
length and genome copy number per virus. Empty and linked EBOV structures were excluded from the histogram data. A single G1-single/comma
shaped EBOV is shown (inset on the right, G1=1 copy of genome). (B) Low magnification cryo-images showing: G1- single/comma shape, G1- single/
linear, G5-continuous (G5=5 copies of genome). (C) High magnification of a G1- (single genome) virion with a region filtered to emphasize the
nucleocapsid. (D) Low magnification image of a G4-linked EBOV, each genome copy is indicated and numbered, the red arrows show the transition
points between nucleocapsids. The circular holes (filled with vitreous ice) appear as lighter regions and the support film (‘‘quantifoil’’) appears dark
grey. A ‘‘linker’’ region is shown at higher magnification (inset).
doi:10.1371/journal.pone.0029608.g001
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configurations are ‘‘single’’ particles, containing a nucleocapsid of
uniform length, (which we postulate to contain one copy of the
genome), ‘‘continuous’’ particles, with nucleocapsids of a length of
the single virion multiplied by an integer of 2 or greater; and
‘‘linked’’ virions composed of a series single-genome nucleocapsids
connected by short sections of empty envelope. Negative staining
can cause drying and staining artefacts which hamper accurate
measurements and preclude 3D analysis. Nevertheless, in previous
studies using this technique, the average length of Marburg virus
Figure 2. Image processing of Ebola virus. Linear 2D averaging of EBOV: the envelope and nucleocapsid are prominent features (A). The line
trace is colour-coded as follows: red, spike; beige, lipid envelope; green, membrane-associated proteins; white, membrane-nucleocapsid gap; blue
and purple, outer and inner nucleocapsid. (B) 2D class averages of envelope plus inner face. (C) VP40 VLPs, showing 2D averages from the from side
regions (first two) and end-on/central regions (last three). In (A–C) representative individual repeats have been highlighted in color using the same
scheme as in (A). (D) Schematic model of the nucleocapsid and envelope, highlighting the relative distribution of NP to VP40. (E,F) 3D reconstruction
of the nucleocapsid with the same colour scheme as in (A). The location of the inner nucleocapsid, and the bridge are indicated. The reconstruction is
presented at a volume threshold that would encompass a single copy of each of these proteins, and the viral RNA. In (E) the vertical (protein-protein)
and horizontal (protein-RNA) contacts are indicated by yellow and white arrows, respectively. (G) Various recombinant nucleocapsid-like structures,
and authentic EBOV, which have been studied by electron microscopy [14,15,21,28]. 3D schematics of these structures highlighting the RNA and
protein composition and the diameter of these structures, at the same scale for comparison to (E).
doi:10.1371/journal.pone.0029608.g002
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latter is very similar to the mean length of 982 nm measured in the
current study by cryo-TEM of frozen hydrated specimens. In
addition, discrete sub-populations of virions of double or triple the
average length were also previously reported in centrifuged virus
preparations [21].
We also observed ‘‘empty’’ filaments that lack nucleocapsids,
with a random length and a smaller diameter (Figure S1C). These
empty nucleocapsids are also visible in previously published thin-
section micrographs of human EBOV infected pathology
specimens, e.g. [23], and are thus probably not an artifact of cell
culture. It is also unlikely that the polyploidy we have observed in
EBOV is a peculiarity of the particular viral isolate or of the Vero
cell line that we used for this investigation. Previous studies using
negative stain EM have shown that both Marburg virus and
several different EBOV species can produce filamentous virions up
to 14 mm long when grown in several different cell lines [21,22].
Blood specimens from Guinea-pigs and monkeys that were
inoculated with primary isolates of the Marburg agent, when
centrifuged and observed by negative stain, also showed
filamentous virions of variable length, with the average reported
as about 1 mm in length but with a smaller proportion being over
2 mm in length [24]. In addition, viral filaments of lengths from 1.4
to 1.6 mm long, and occasionally as long as 2.6 mm, can also be
seen in published ultrathin sections of EBOV infected human and
monkey tissues [23,25]. Thin-section EM always underestimates
the lengths of virions, since filament profiles are frequently
truncated by the section plane: in addition, tissue shrinkage of
10 to 20% during dehydration and resin embedding is common.
Thus, it is probable that polyploid EBOV with multiple
nucleocapsids are also produced in naturally infected humans
and animals, though it is not possible to make a direct comparison
with cell cultured virus: it would be very difficult to obtain large
enough quantities of concentrated virus from animals to carry out
detailed cryo-TEM analysis and measurements.
Nucleocapsid
The Ebola nucleocapsid structure was solved to 19 A ˚ resolution
(FSC 0.5 criteria) using linear regions of 34,605 images (taken at
3–4 mm defocus, Figure 2). Since virus particles were not straight
enough for conventional helical image processing, a combination
of tomography, sub-tomogram averaging, single particle averag-
ing, and the iterative helical real-space construction method were
used [26,27]. The EBOV nucleocapsid is a right-handed double-
layered helix with an outer diameter of 41 nm and a hollow inner
channel 16 nm in diameter as determined by image analysis and
tomography (Figures 2, 3, 4, S2, S4, movie S1). The pitch is
6.96 nm, with 10.81 repeats per helical turn (Figure 2). The inner
nucleocapsid, composed of large subunits, is linked by vertical and
horizontal contacts between the large subunits (Figure 2E,F). The
horizontal contacts occur between the large subunits at a diameter
of 22.3 nm. The vertical contacts linking the coils have a higher
density than the horizontal ones, so we interpret the horizontal
contacts as involving viral RNA (white arrow, Figures 2E, 4E;
movie S1) and the vertical contacts as protein-protein interactions
(yellow arrow, Figure 2E). The NP subunits are also linked by an
outer horizontal layer at a diameter of 37 nm. This layer consists
of a ring of bridges between adjacent large subunits (Figure 2). The
bridges joining the NP subunits are composed of two lobes, one of
which of which is slightly bigger than the other. Previous studies
that produced recombinant nucleocapsid-like structures showed
that expressed VP24 and VP35 both independently associate with
Figure 3. Electron tomography of Ebola virus. (A–C) Cryo-EM images of; (A) VP40-GP VLP, (B) VP40 VLP, and (C) EBOV. (D–F) Electron tomogram
of VP40-GP VLP showing; (D) a single X–Y slice cutting through the spikes at the top of the VLP, (E) a single X–Y slice cutting through the central
region of the VLP, and (F) a X–Z average of 50 slices showing a cross section of the VLP. (G–H) Electron tomograms of EBOV showing; (G) a single X–Y
slice cutting through the central region of the virus, and (H) a X–Z average of 50 slices showing a cross section of the virus. The insets in (G) are image
averages of the nucleocapsid (bottom), and the entire width of the virus (top). (I) 3D shaded surface representation of the EBOV tomogram, individual
spikes (red oval) and connective regions between the nucleocapsid and membrane proteins (red rectangle) have been highlighted. (J) Surface
distribution of the spikes on the VP40-GP VLP tomogram shown in (D–F), the envelope has been replaced with an orange cylinder, and spike
locations are indicated by white spheres. (K) 3D model of EBOV using the data from Figs. 2, 3, 4. Color coding as follows: red, spike; white spheres,
spike location; beige/orange, lipid envelope; green, membrane associated proteins; blue and purple, outer and inner nucleocapsid. Colour-coded
arrows in (A–H) highlight equivalent features in the 2D analysis shown in Fig. 2.
doi:10.1371/journal.pone.0029608.g003
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,50 nm diameter helical nucleocapsid-like structures. When
VP35, VP30, VP24, and NP were transfected together, approx-
imately 50 nm diameter helical nucleocapsid-like structure was
also generated, whereas NP alone generated helical NP-RNA
complexes ,20–25 nm in diameter, which were nuclease sensitive
[14,28,29]. Taken together these results suggest that VP24 and
VP35 are the structural components of the bridge located on the
periphery of the nucleocapsid (Figure 2G). It is not possible to
accurately delineate VP24 and VP35 within the bridge at this
resolution, however the density of the bridge is consistent with a
predicted total mass of 60 kD, thus each bridge is composed of one
molecule of VP24 and one molecule of VP35. It is likely that the
larger lobe is VP35 and that VP24 therefore resides within the
smaller lobe (Figure 2F). Thus, each bridge is composed of a
VP24-VP35 heterodimer that holds adjacent NP molecules
together horizontally. This structure explains how VP24 and
VP35 are able to independently interact with NP, and why all
three are required for the formation of a double-layered
nucleocapsid. In addition, it implies that VP24 and VP35 can
interact with each other as well as each interacting with a different
site on the NP molecule in order to make an oligomeric structure.
The recombinant nucleocapsid data indicates that both VP35-
VP30-VP24-NP and VP35-VP24-NP produce approximately
50 nm diameter helical structures that are indistinguishable from
nucleocapsids produced by EBOV. This indicates that VP30 does
not increase the diameter of the nucleocapsid. We propose that
VP30 lies in the interior of the nucleocapsid and is not part of the
bridge on the periphery of the nucleocapsid. This localization is
consistent with previous work showing that VP30 is a component
of the nucleocapsid, and associates with NP, but is non-essential
for nucleocapsid formation [14,30,31]. Our model, in which the
inner layer at 22.3 nm diameter is RNA-NP, and the outer bridge
centered at 37 nm is composed of VP24-VP35 heterodimers, with
VP30 bound to NP, is thus consistent with these previous
observations [14,28,29], and suggests that the outer VP24-VP35
Figure 4. Sub-tomogram averaging of Ebola virus. (A–D) Sections of the density map of the sub-tomogram average are shown from the top
sliced just below the envelope (A), the middle of the virus (B), a side view of the virus (C), and an end-on slice (D). Putative locations of several VP40
proteins adjacent to the membrane are circled. (E,F) Images showing just the nucleocapsid. The helix is right handed (arrow in E). No helical symmetry
was applied to this data. Color coding as follows; beige, lipid envelope; green, membrane associated proteins (VP40); blue and purple, outer and
inner nucleocapsid.
doi:10.1371/journal.pone.0029608.g004
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tion of the nucleocapsid.
We have modeled the arrangement of the RNA within the
EBOV nucleocapsid (Table S2). Since no atomic resolution data
on the ribonucleoprotein structure of filoviruses have yet been
reported, the ribonucleoprotein ring-structures of other members
of the mononegovirales are useful for comparison. Although the
mass of the nucleoproteins, and the number of nucleotides per
subunit differs amongst these virus families, a model of the 18.9 kb
EBOV genome with the RNA following a circular fixed radius as
in respiratory syncytial virus (RSV) [32] would make a
nucleocapsid containing one copy of the EBOV genome about
914 nm long (Table S2). This fits closely with the 982 nm length
class (53% of the particles observed in this study) containing a
single copy of the EBOV genome threaded through the NP at a
fixed radius. Allowing 33 nm of space for the membrane envelope
to curve around at each end of the virus particle gives an estimated
length for a single-genome virus particle of 980 nm, which is very
close to that observed (982679 nm). The majority of the virus
particles fall into size categories that are a multiple of the putative
single genome length (G1), giving size classes of 1.960.15 mm (G2:
18.7% of the particles having 2 genomes); 2.960.2 mm (G3: 12%
of particles having 3 genomes) and so on (Figure 1A and Table S1)
. The length of the longest particle measured was consistent with
having 22 genome copies. Our model predicts a nucleotide to NP
ratio of 13.0 (Table S2), which is within the range of 12 to 15
nucleotides per NP molecule as measured by biochemical studies
of Marburg virus [33].
Figure 5. 3D structure of the Ebola spike. The density map of the EBOV GP spike viewed from the side, end-on, and side (with envelope) shows
the docked GP1–GP2 structure in yellow (PDB entry 3CSY [42]), glycosylation sites (green), and receptor binding site (RBS; red, highlighted). (A) The
reconstruction showing the spike (orange) and the envelope (beige). (B) Difference map generated by subtracting the docked structure from
reconstruction of the entire spike. The color scheme shows the following putative regions; green, mucin domain; pink, deletions 190–213, 279–298;
purple-blue, GP2 stalk. The docked KZ52 neutralizing antibody is shown in purple.
doi:10.1371/journal.pone.0029608.g005
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to 98 nm, while empty viral filaments are 48 to 52 nm in diameter.
In partially full virions, the membrane envelope is constricted at
the transition point where the nucleocapsid ends and the empty
membrane tube begins (Figures 1, S1C). Empty virions (Figure
S1C) have a similar structure to VP40-GP virus-like particles
(Figure 3A). Both full and empty virions have a continuous layer of
spikes projecting from the surface (Figures S1, S2, S3, movie S2),
giving an overall diameter of 120 nm for full particles. The
majority of virions are linear (Figures 1, S1A, S5), others have a
‘‘comma-shaped’’ appearance, with a globular head containing
portions of the nucleocapsid that are curled-up or bent at one end
(Figures 1A,B and S1B). It is clear that ‘‘toroidal’’ virions
previously identified by negative staining [22,34] are a variation
of comma-shaped virions. Internal vesicles of 20–40 nm in size are
also sometimes observed at the ends of virions (Figure S1D). These
vesicles appear to be formed during the process of envelopment of
the nucleocapsid, since they were not observed in preparations of
VP40 or VP40-GP VLPs. VP40 VLPs had wavy envelopes with an
irregular diameter ranging between 48 nm and 142 nm (N=49)
compared to VP40-GP VLPs which were more ordered with a
diameter between 50 nm and 91 nm (N=26), (Figure 3). Thus the
presence of GP, and certain contacts between the GP and VP40,
play a part in stabilizing the tubular membrane envelope structure,
and our observed structure agrees with previous reports that GP
enhances VP40 VLP budding [35,36]. The previously reported
‘‘branched’’, filamentous forms [34] were rarely observed: these
consist of empty tubes (data not shown). It is possible that
centrifugal virus purification disrupted most branched structures
that were seen previously with negative staining of cell culture
supernatant.
The VP40 matrix protein shows a regular 5 nm lattice spacing
(Figure 2B, C). Both the nucleocapsid and the VP40 layers are
ordered, however the contacts between them appear to be non-
symmetrical (Figure 2D), implying some flexibility in their inter-
molecular contacts. It has been shown that VP35 interacts with
the VP40 and can be packaged into VP40 VLPs [37]. The
localization of the VP24-VP35 bridges on the periphery of the
nucleocapsid, may allow interactions of one or more of the
nucleocapsid proteins with VP40, possibly through projecting
low-density protein loops. There is a 6–7 nm gap of low density
between the nucleocapsid and the VP40 layer, but tomography
also shows discrete areas of connectivity between the nucleocap-
sid and matrix protein layers, which may be connections between
the envelope and the nucleocapsid (Figure 3I). These results are
substantiated by the analysis of sub-tomograms where helical
symmetry is clearly evident but was not imposed (Figures 4, S4).
The use of sub-tomogram analysis improves the resolution of the
data by averaging sub-tomograms together which are at different
angular orientations. The helical nucleocapsid is clearly identified
in the structure, including the gap between the envelope-VP40,
and the nucleocapsid-VP40. The right-handed pitch of the helix
is clearly discernable (Figure 4E), as well as the putative location
of several VP40 proteins, although the resolution of the
tomographic data by itself is slightly lower than with single
particle analysis.
Figure 6. Schematic model of Ebola virus genome packaging. EBOV appears pleomorphic, but an underlying structural organization is
maintained. In the model we show the three basic morphological forms of EBOV particles; empty, linked, and continuous. Single genome (G1) virus
and multi-genome particles are shown budding from the cell. In this model genomes are assembled in the host cell and transported to the surface
where the end-to-end apposition that we have observed by cryo-EM in mature virions takes place during (or prior to) budding and envelopment at
the plasma membrane. The color-coding is as follows: nucleocapsids, red, yellow and orange helices; nucleocapsid protein, purple spheres; VP40,
green ovals, VP24/VP35 bridges, blue oval; GP spikes, red; microtubules, brown.
doi:10.1371/journal.pone.0029608.g006
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also allows estimation of the stoichiometry of the major structural
proteins (Figure 3, movie S2). Both EBOV and VP40-GP VLPs
have an irregular distribution of the GP spikes on the surface
(Figures 3, S3) demonstrating the lack of any ordered lattice-like
arrangement with the matrix protein VP40. The spikes are
clustered, and the average centre-to-centre spacing is 15.2 nm
(Figure S3, and movie S3). We calculate that a virion of 982 nm in
length would have about 1888 copies of the GP spike, and 8391
copies of VP40. The wide spacing of the EBOV GP in the viral
envelope allows plenty of space for free access and binding of any
neutralizing antibodies directed at both the club-shaped head and
stem region without stearic hindrance (Figures 3J, S3).
The nucleocapsid structure implies equimolar ratios of NP,
VP24, VP30, and VP35. A genome of 18.9 kbp with 13 bases per
NP with a single genome copy gives 1454 molecules of NP, VP24,
VP30, and VP35 per virion. Previous analyses of Coomassie blue
stained gels of purified EBOV predicted 625, 1208, 833, and 2686
protein molecules of NP, VP24, VP30, and VP35, per virion
respectively [38], which is in the same stoichiometric range as
predicted by our model for the nucleocapsid, taking into account
the variability of individual protein band staining by Coomassie
blue, which is affected by factors such as distance of migration
[39], basic amino acid content [40], and the extent of glycosylation
[41]. Since NP is glycosylated, we anticipate underestimation of
the NP content of virions [14,41].
GP spike
The GP spike is necessary for cellular attachment and fusion of
EBOV. A definitive cell surface ligand for the receptor binding
domain has not been identified, and a number of different cell
surface proteins are able to enhance infection [42,43]. Cleavage of
GP results in two domains: GP1 containing the receptor binding
domain and GP2 that contains the fusion and transmembrane
domains. The structure of a smaller engineered fragment of GP1–
GP2 has recently been determined by x-ray crystallography (3CSY
pdb [42]). We determined the structure of the entire EBOV GP
trimeric spike at a resolution of 14 A ˚ (FSC 0.5 criteria), by
combining sub-tomograms from the spikes of VP40-GP VLPs (234
images) with EBOV images for the side perspective data (8084
images) using projection matching as previously described [44]
(Figure 5 and movie S4). In our reconstruction, the spike is in situ in
the viral membrane, thus the transmembrane region and base of
the spike, adjacent to the membrane, are less well defined than the
distal region of the spike, due to the smaller differences in contrast
between lipid and protein versus water and protein, as well as
Fresnel fringes at the edge of the viral membrane. The spike
extends 10 nm from the surface of the envelope, with a club-
shaped head 6.5 nm in height, and a 3.5 nm long stalk. Docking of
the previously determined X-ray structure into our cryo-EM map
shows a good fit, with a correlation coefficient of 0.75 using the
docking and correlation program SITUS [45]. The difference map
calculated between our cryo-EM map and the GP1–GP2 structure
identified volumes corresponding to the domains deleted to
generate the 3CSY GP1–GP2 structure (Figure 5). We show that
the mucin-like domains (connected at V310 and E502 - shown in
Green in Figure 5) completely fill the previously described bowl-
like chalice which contains the putative receptor binding sites [42].
The proximity of glycosylation sites in the GP1–GP2 structure
suggests that the distal density of the spike contains the glycans that
were deleted in order to construct the GP1–GP2 structure. In
addition, each mucin-like domain has an ‘‘arm-like’’ projection,
which extends radially at the distal end of the spike, to a maximum
diameter of 13 nm. The localization of the mucin-like domain is
consistent with previous studies showing that endosomal proteol-
ysis plays a role in enhancing infectivity as well as binding of the
Ebola GP to the plasma membrane [46,47].
The other two major deletions in the 3CSY structure (N278-
R299 and A189-Y214) are situated at the midpoint of the structure
just above the stalk (shown in pink in Figure 5). Inclusion of the
KZ52 Fab in the docked structure demonstrates that this
neutralizing epitope (from a human survivor) is localized on the
side of the stem region of EBOV GP trimer at the base of the club-
shaped head, and that the Fab domain lies close to the lipid
envelope when bound, and approximately tangential to the viral
envelope. The densities putatively corresponding to N278-R299
and A189-Y214 are close to the KZ52 neutralizing site, but do not
obstruct antibody binding. The mucin-like domains are out of the
way and cannot interfere stearically with KZ52 Fab binding. This
is consistent with previous results indicating that KZ52 binding
does not require cathepsin cleavage [48]. We have thus delineated
the low resolution structure of the glycocalyx or ‘‘glycan cap’’ that
covers the distal end of the uncleaved EBOV GP spike, which is
consistent with a proposed role in immune evasion [42]. Our data
will enable docking of future structures to investigate receptor
binding, antigenicity, and fusion mechanisms.
We have shown that EBOV particles are capable of a high
degree of polyploidy, made possible by the extreme length
polymorphism of budding virus particles. Polyploidy in filoviruses
may be more extensive than in any other virus family, with 46% of
virions having more than one genome copy, and some having up
to 22 copies. Polyploidy has been shown to increase infectivity
rates in paramyxovirus and birnavirus [2,3]. Attempts to
investigate infectivity rates of EBOV by centrifugal fractionation
of the different sized particles are stymied by the extreme
filamentous morphology, as well as that fact that EBOV of
different lengths have the same buoyant density (personal
observations). A complex double layered helical nucleocapsid
appears to be unique to filoviruses. In the case of rhabdoviruses,
the bullet-shaped nucleocapsid precludes them from being linked
sequentially. Although some influenza strains can produce
filamentous virions, this morphology appears to be driven by the
matrix protein only [49]. A filamentous morphology may have
evolutionary implications by allowing genome length flexibility. It
could also enhance the ability for viral dissemination in infected
tissues, for example by diapedesis of budding filamentous virions
through epithelial layers.
Materials and Methods
Cells and viruses
Zaire Ebolavirus was propagated in Vero E6 cells and purified
as previously described [50]. Ebola enriched samples were checked
by SDS-Page and Western blotting, and rendered non-infectious
by fixation with 4% paraformaldehyde. Excess fixative was
removed by placing the fixed samples in a Slide-A-Lyzer G2
cassette with a 0.5 ml capacity, and a 10,000 MWCO (Thermo
Scientific Pierce Protein Research Products, Rockford, Illinois,
USA), followed by dialysis against PBS. Virus-like particles were
produced as previously described [51]. All work with infectious
Ebola virus (virus culture and purification) was performed in the
biosafety level 4 laboratories at the National Microbiology
Laboratory of the Public Health Agency of Canada, Winnipeg,
Manitoba.
Cryo-electron microscopy
Samples for cryo-electron microscopy (cryo-EM), and cryo-
electron tomography (cryo-ET) were mixed with BSA coated
Organisation of Ebola Virus
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Accessories, Wageningen, The Netherlands) at a ratio of 2:1
(virus:gold) for cryo-ET, and (9:1) for cryo-EM. Specimens (4 ml)
were then applied to glow-discharged quantifoil grids with 2 mm
holes spaced at 1 mm intervals (Quantifoil MicroTools GmbH,
Jena, Germany). Grids were subsequently plunge cooled in liquid
ethane using a Vitrobot Mark IV (FEI Company, Hillsboro,
Oregon, USA). Specimens were transferred to a Tecnai 20 G2
transmission electron microscope (FEI) operated at 200 kV,
equipped with a Gatan CT3500TR single tilt rotation low-
temperature specimen holder. For cryo-EM imaging was con-
ducted at temperatures of ,2185uC. Images were recorded using
an Eagle 4K CCD camera (FEI Company, Hillsboro, Oregon,
USA). For single particle image analysis, images were taken at
50,0006 or 80,0006 magnification at 2–4 mm defocus, with a
dose of 10 electrons/A ˚ 2. This corresponded to a pixel size at the
CCD detector of 2.147 A ˚/pixel and 1.353 A ˚/pixel, respectively.
For virus length measurements low magnification cryo-EM images
were taken at 5,0006, 3,5006 and 2,5006. For cryo-ET single
axis tomograms were taken at 25,0006, 29,0006 or 50,0006
magnification, at 28 m or 26 m defocus, with angle steps of
2u24u. Data were collected within tilt ranges of 660u,o r652u,
with a total dose/tomographic data set of 47–60 electrons/A ˚ 2. For
cryo-EM, data collection was done using the low-dose unit and
software coupled with the TEM Imaging & Analysis (TIA)
software (FEI Company, Hillsboro, Oregon, USA). Automated
eucentricity determination, and focusing were performed using the
Xplore3D data acquisition software (FEI Company, Hillsboro,
Oregon, USA). For cryo-ET, data collection was done using the
Xplore3D data acquisition software, the low-dose unit, and the
TIA software (FEI Company, Hillsboro, Oregon, USA).
Image processing: virus length measurements
The exact magnification in the microscope at the CCD detector
was determined using a calibration grid (Pelco International,
Redding, CA). Ebola virus length measurements (n=2090) were
made using the Image J software package [52] using the free hand
line tool, and the analyse/measure function. For this analysis only
viruses containing a continuous nucleocapsid were measured.
Viruses with linked nucleocapsids and empty viruses were omitted.
The measurements that were made in image J were then collated,
analysed, and plotted, using Microsoft Excel.
Tomography: image processing
Tomographic image analysis of cryo-ET data was carried out
with the Inspect3D Xpress software package (FEI Company,
Hillsboro, Oregon, USA). The tomographic images were aligned
to each other by a two-step process. The first step involved
alignment of adjacent images by cross correlation. This process
was repeated several times until the shift between adjacent images
was below one pixel in either the X or Y plane. The second step
involved the alignment of the entire image stack using 10 nm
colloidal gold particles as fiducial markers. In this instance the
term ‘‘image stack’’ refers to all the images collected in a single
tomographic tilt. This procedure involves the selection of ten to
twenty of the 10 nm gold particles and the subsequent
identification and tracking of these particles in all of the images
in the image stack. The locations of these particles are then used in
conjecture with the tilt angles of each image to globally align all of
the images to each other. The last step in this process was to
calculate the three dimensional reconstruction of the tomogram
from the aligned images. In this study we used the simultaneous
iterative reconstruction technique (SIRT) algorithm with 10
iterations to calculate the final three-dimensional reconstruction
(tomogram).
Sub-tomogram analysis
Sub-tomogram image analysis of cryo-ET data was carried out
with the Automated Recognition of Geometries, Objects, and
Segmentations (ARGOS) software package (FEI Company,
Hillsboro, Oregon, USA). For this analysis an 80
3 pixel sub-
tomogram was extracted from a tomogram using the Chimera
[53] software package. In this analysis the tomogram used
contained a linear region of the Ebola virus (Figure S4), and the
80
3 pixel sub-tomogram contained a single linear segment. This
template was then used by the ARGOS software to conduct an
exhaustive search of the original tomogram for similar structures.
This analysis involved a six dimensional search matrix (three
positional variants, and three rotational variants). The entire
search process was sped up by the ARGOS software by utilizing
parallel processing on the computer’s graphics processing unit
(GPU). Once individual sub-tomograms were selected based on
correlation, they were inspected and compared to the initial
template sub-tomogram. The extracted and aligned sub-tomo-
grams were subsequently averaged with a filter that minimized the
missing wedge artifact. This average structure then was used as the
reference and the entire procedure was repeated several times.
Single particle image analysis: software and hardware
Single particle cryo-EM image processing was carried out using
the EMAN/EMAN2 and SPIDER/WEB image processing
program packages [54,55]. Particle selection (EMAN) and contrast
transfer function correction (EMAN2) were conducted on an
Apple Inc. Mac Pro computer (12-core, Intel Xeon Nehalem
processors 2.93 GHz, 32 GB Ram, Mac OS X 10.6.7). All
subsequent calculations were performed on a Dell PowerEdge
R900 4-way 64-bit Xeon X7460 processors, Six Core 2.67 GHz
CPUs with 256 GB Ram running Linux (CentOS 5.2). Images
were corrected for contrast transfer function (ctf) using the
‘‘e2ctf.py’’ function in the EMAN2 software package
5, which
estimates defocus and corrects for ctf by phase-flipping. Images of
the spike (n=8084 side perspective; n=234 end-on perspective)
and nucleocapsid (n=34,605) were selected for image analysis.
The resolution of the cryo-EM reconstruction was estimated by
Fourier shell correlation using the FSC 0.5 criteria. In all
subsequent sections image analysis procedures were conducted
using the SPIDER software package unless otherwise stated.
Single particle image analysis: nucleocapsid analysis
Analysis of initial images of the ‘‘straight’’ linear segments of the
Ebola virus using Fourier transformation indicated that there was
sufficient bending of the helical nucleocapsid to make standard
helical analysis problematic. Therefore, an initial reference free
single particle 2D analysis was conducted in EMAN using the
‘‘startnrclasses’’ program to identify any potentially recurring
motifs within linear regions of the Ebola virus.
In order to further investigate the nucleocapsid repeat identified
in the 2D analysis the iterative helical real space reconstruction
method (IHRSR) was implemented [26,27]. This procedure
requires an initial 3D helical reference structure which is used
for image alignment. In this investigation a linear region of the
Ebola virus which was extracted from a tomogram was used to
generate this helical reference structure. This initial 3D structure
was first pre-treated with a Gaussian mask to select only the
nucleocapsid-containing region of the virus tomogram. An auto
correlation function was then performed in which the volume was
rotated around the helical axis, and translated along the axis of the
Organisation of Ebola Virus
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autocorrelation value was calculated (between the shifted and un-
shifted volume). The net result of this process was the
determination of the helical symmetry present in the tomogram.
In order to analyse the data generated by this procedure the
Microsoft excel spread sheet program was used. The correlation
plots generated by this process solved the handedness, pitch, and
number of repeats per turn for the nucleocapsid. These symmetry
parameters were then applied to the tomogram to generate the
initial 3D model. The IHRSR method was then applied to the
34,605 single particle images of the nucleocapsid as previously
described [26,27].
Single particle image analysis: spike analysis
For the spike dataset two image populations were combined
composed of side, and end-on perspectives. For the side view
perspective images were subfield directly off of the Ebola virus
cryo-EM images. For the end-on perspectives sub-tomographic
volumes were extracted from the tomographic reconstructions of
the Ebola VLP. The 3D volumes were then added in the ‘‘Z’’
plane to generate 2D projection averages which were then used for
the subsequent single particle image analysis. The data were the
processed using EMAN to generate an initial 3D reconstruction,
which was then refined in SPIDER using the projection matching
technique as previously described [44,56]. The docking of the
3CSY.pdb [42] structure to the cryo-EM structure of the spike was
accomplished using the SITUS [57] software package with the
exception that only the GP1 and GP2 components of the 3CSY
structure were used for the docking process. The ‘‘floodfill’’
program in SITUS was used to segment the spike component of
the 3D cryo-EM reconstruction from the envelope component of
the reconstruction. The segmented volume was then used for the
docking procedure using the ‘colores’ function in SITUS. Once
docked the entire 3CSY.pdb structure which included the Fab of
the KZ52 neutralizing antibody was superposed over the docked
GP1/GP2 component of the structure.
Structure visualisation
The 3D cryo-EM reconstructions, cryo-ET reconstructions, 3D
models of the Ebola virus, and the atomic resolution structure
3CSY.pdb were visualized using UCSF Chimera software package
(Computer Graphics Laboratory, University of California, San
Francisco, supported by NIH P41 RR-01081) [53]. The 3D
images and movies presented in this manuscript were generated
directly by UCSF Chimera software package.
Supporting Information
Figure S1 High magnification images showing linear
regions of Ebola virus. The diameter of EBOV is constant in
linear regions of the virus containing a nucleocapsid (A). The viral
filaments are not perfectly straight, and are often curved,
complicating helical image processing. Glycoprotein spikes (GP),
envelope (E), and nucleocapsid (NC) are all clearly visible. The
black spherical objects (shown by black arrows) are 10 nm
colloidal gold particles which are used for automated focusing
and tomography alignment. (B) Images of ‘‘comma-shaped’’ Ebola
virus. Each of the comma-shaped viruses has a single copy of the
genome which can be seen running through the center of the virus
and curving at one end of the virus to form the globular head. In
some of the heads there is a low-density region (LD) devoid of
nucleocapsid. In others, the nucleocapsid is sharply bent where it
folds back on itself and looks like a check mark (right panel). (C)
Ebola virus structures with and without nucleocapsid. Empty
tubular filaments (E), and viral filaments containing a nucleocapsid
(NC) are shown. Constrictions at the transition points where the
nucleocapsid ends and the viral membrane continues as an empty
tubular structure are indicated by red arrow heads. The diameters
are as follows: nucleocapsid, 41 nm; virus with nucleocapsid, 96–
98 nm; empty filaments, 48–52 nm. (D) Ebola virus with interior
vesicles. Viral particles containing additional membrane vesicles
within the envelope are shown by a green ‘‘V’’. Although present
in a minority of virus particles, when present they are usually at the
ends of the virus with a globular head. The image in the left hand
column shows an example where the vesicles are in the middle of
the virus.
(TIF)
Figure S2 Tomographic slices of Ebola virus. Slices in
‘‘Z’’ of Ebola virus tomogram reveal the components of the virus
and nucleocapsid (A). The insets show 2D averages of the
nucleocapsid. The slice through the top of the virus reveals the
envelope and glycoprotein spikes. The next slice cuts through the
top of the nucleocapsid (NC) revealing the banding pattern which
represents VP24–VP35 bridge. The third slice cuts through the
middle of the NC. The tube-like component of the NC is primarily
composed of NP. The last panel shows the average of 53 slices
which make up the volume encompassing the entire NC. The
image and the average in the inset contain all structural
components of the NC. (B) The linear region of the tomographic
nucleocapsid reconstruction (A) was translated in Z and rotated
360u in plane. At each shift/rotation point the volume was
correlated to the initial (un-shifted) volume. The correlation plot is
shown as a grey scale image. Eight regions have been highlighted
demonstrating a characteristic right-handed helical pattern. (C).
For comparison, both left and right handed helical correlation
plots are shown. (D), Region three is shown, with the locations of
correlation maxima shown with an X. The angular distance
between each maximum was calculated from several plots. A total
of 71 measurements gave an average angular distance of 33.6u+/
28.5u between helical repeats, resulting in 10.7 repeats per turn.
Using the 6.96 nm pitch (Fig. S8) the step in Z per helical repeat
was calculated as 0.65 nm. These helical symmetry values were
then imposed on the nucleocapsid tomogram and this structure
was used as the initial reference volume for refinement using the
iterative helical real space reconstruction method.
(TIF)
Figure S3 Surface spike distribution in the Ebola VLP.
Longitudinal Z-slices through the top and middle of the particle
are shown, as well as the end-on view (A). The tomogram is shown
as a shaded surface at a density threshold that indicates the spikes
(B). The volume from one side of the tomogram has been
extracted, and a red-blue color scheme shows the depth at which
the spikes are located. This region of the envelope has a surface
area of 15,651 nm
2. Selected spikes have been identified by red
circles, the single particle reconstruction of the spike is shown at
the same scale to the right in a red square for comparison. The
same region in (B) is shown in (C) with a solid orange cylinder to
provide a visual cue for the viral envelope. Eighty-six individual
spikes were counted (white spheres) and have a patchy distribution
(D), each spike would occupy an average area of 182 nm
2, giving
an average spacing between spikes of 15.2 nm. The reconstruction
of the spike (blue) with the docked KZ52 Fab (purple) has been
included to show that there is ample room for antibody
attachment.
(TIF)
Figure S4 Extraction of Ebola nucleocapsid structure
for sub-tomographic analysis. The tomogram of a linear
Organisation of Ebola Virus
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tomogram analysis (A). When viewed along the helical axis (Y) or
from the end perspectives (X,Z) the basic components are visible.
The tomographic volume was also cylindrically masked along the
X-axis, selecting only the density containing the nucleocapsid, to
highlight the components of the nucleocapsid in the tomogram (B).
Two-dimensional single particle image analysis was carried out
with cryo-images (C) (not tomographic data sets), for comparison
to the 3D tomographic data. The average shown in this panel was
generated by reference free classification, using the ‘‘startnrclasses’’
program in EMAN [54]. The 6.96 nm helical pitch can be easily
seen in the 2D average, but is also visible in the projections of the
tomographic volume in (A, B).
(TIF)
Figure S5 Representative low-magnification images of
Ebola virus. Frozen hydrated virus is clearly visible with sections
of the filamentous virus over both the support film and across the
holes in the quantifoil film. Individual G1 (single genome copy)
virus is circled in red, several sections containing a nucleocapsid
are indicated by a blue arrowhead, and regions without a
nucleocapsid are indicated by a magenta arrowhead. Globular
heads are identified by yellow arrowheads. In this image the circles
(light grey, 2 m diameter) are filled with frozen hydrated virus in a
thin aqueous layer, and the quantifoil support film appears as
darker grey.
(TIF)
Table S1 Length analysis of ‘‘continuous’’ Ebola virus particles.
The length of 2090 EBOV particles were measured using ImageJ
[52]. The values in the ‘‘model length’’ column are based on
multiples of the G1 mean length. The values in the in the ‘‘mean
length’’ column were calculated directly from the data. Only full
particles containing a continuously packaged nucleocapsid were
measured, all others (linked-nucleocapsid and empty particles)
were omitted from this analysis. The terms G1–G22 indicate the
number of genomes/viral particle (i.e. G22=22 genomes). All
measurements are in mm.
(TIF)
Table S2 Modeling of RNA in the Ebola nucleocapsid. Two
previously determined atomic resolution structures of negative
stranded RNA viruses (VSV (2GIC.pdb) [58], and RSV
(2WJ8.pdb) [32]) were used to estimate the EBOV nucleocapsid
length and number of nucleotides per nucleoprotein. Images of
VSV (A) and RSV (B) are shown as a molecular surface with the
protein in orange and the RNA as a green ribbon. From left to
right, they show a surface view from the side, a side-on cross
section, an end-on view, the RNA density alone in projection, and
a rotational average of the projection. The VSV-based estimate,
with a saw-tooth pattern of RNA in the helix, gave a nucleocapsid
which 614.37 nm long, too short for the measured length of the
G1 EBOV (982 nm). The RSV-based model, with a relatively
straight/circular pattern of RNA in the helix predicted a
nucleocapsid 914.55 nm long, which closely fits the measured
length of G1 virions, after allowing ,34 nm space at each end to
accommodate the curve of the envelope containing GP spikes and
matrix proteins. The RSV-like model gives 13 nucleotides per
nucleocapsid protein which is similar to previous biochemical
estimates of 12–15 for Marburg virus [33], suggesting that the
RNA in the EBOV nucleocapsid is arranged in a smooth helical
pattern at a diameter of ,22 nm.
(TIF)
Movie S1 3-D reconstruction of Ebola virus nucleocap-
sid. This movie shows the three-dimensional structure of the of
the Ebola virus nucleocapsid as shaded surface representation.
The surface is set at a density threshold which would include one
copy of NP, VP24,VP30, VP35, and the RNA. The nucleocapsid
rotates, and then is sliced through the Z-axis to show the internal
components of the structure.
(MOV)
Movie S2 Tomogram of Ebola virus. This movie shows
slices in ‘‘Z’’ through a cryo-electron tomogram of a linear region
of Ebola virus. The slices which are in the Z-plane pass back and
forth through the virus showing various components such as the
surface glycoprotein spikes and the nucleocapsid in the interior of
the virus.
(MOV)
Movie S3 Ebola virus spike distribution. This movie
shows one surface of a cryo-electron tomogram of an Ebola virus-
like particle, generated by expressing the VP40 and GP proteins.
The structure rotates showing the distribution of spikes. The
locations of individual spikes are identified by white spheres, and
the reconstruction is replaced by a cylinder to show the patchy
distribution of spikes on the surface of the virus-like particle.
(MOV)
Movie S4 3-D reconstruction of Ebola virus spike. This
movie shows the three-dimensional structure of the of the Ebola
virus GP spike. The structure rotates showing views from different
angles, and indicates the location of the docked 3CSY.pdb [42]
structure with the GP1 and GP2 domains and KZ52 antibody
(purple).
(MOV)
Acknowledgments
We thank B. Szklarczuk and S. Silcox for compiling the movies.
Author Contributions
Conceived and designed the experiments: TFB DRB. Performed the
experiments: DRB SLdV LLL MJR PLM SLH. Analyzed the data: TFB
DRB. Contributed reagents/materials/analysis tools: SMJ. Wrote the
paper: DRB TFB.
References
1. Caspar DL, Klug A (1962) Physical principles in the construction of regular
viruses. Cold Spring Harb Symp Quant Biol 27: 1–24.
2. Hosaka Y, Kitano H, Ikeguchi S (1966) Studies on the pleomorphism of HVJ
virons. Virology 29: 205–221.
3. Luque D, Rivas G, Alfonso C, Carrascosa JL, Rodriguez JF, et al. (2009)
Infectious bursal disease virus is an icosahedral polyploid dsRNA virus. Proc
Natl Acad Sci U S A 106: 2148–2152.
4. Noda T, Sagara H, Yen A, Takada A, Kida H, et al. (2006) Architecture of
ribonucleoprotein complexes in influenza A virus particles. Nature 439: 490–492.
5. Geisbert TW, Hensley LE (2004) Ebola virus: new insights into disease
aetiopathology and possible therapeutic interventions. Expert Rev Mol Med 6:
1–24.
6. Jones SM, Feldmann H, Stroher U, Geisbert JB, Fernando L, et al. (2005) Live
attenuated recombinant vaccine protects nonhuman primates against Ebola and
Marburg viruses. Nat Med 11: 786–790.
7. Feldmann H, Jones S, Klenk HD, Schnittler HJ (2003) Ebola virus: from
discovery to vaccine. Nat Rev Immunol 3: 677–685.
8. Sanchez A, Trappier SG, Mahy BW, Peters CJ, Nichol ST (1996) The virion
glycoproteins of Ebola viruses are encoded in two reading frames and are
expressed through transcriptional editing. Proc Natl Acad Sci U S A 93:
3602–3607.
9. Volchkov VE, Becker S, Volchkova VA, Ternovoj VA, Kotov AN, et al. (1995)
GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and
vaccinia virus polymerases. Virology 214: 421–430.
Organisation of Ebola Virus
PLoS ONE | www.plosone.org 11 January 2012 | Volume 7 | Issue 1 | e2960810. Brindley MA, Hughes L, Ruiz A, McCray PB, Jr., Sanchez A, et al. (2007) Ebola
virus glycoprotein 1: identification of residues important for binding and
postbinding events. J Virol 81: 7702–7709.
11. Kuhn JH, Radoshitzky SR, Guth AC, Warfield KL, Li W, et al. (2006)
Conserved receptor-binding domains of Lake Victoria marburgvirus and Zaire
ebolavirus bind a common receptor. J Biol Chem 281: 15951–15958.
12. Manicassamy B, Wang J, Jiang H, Rong L (2005) Comprehensive analysis of
ebola virus GP1 in viral entry. J Virol 79: 4793–4805.
13. Mpanju OM, Towner JS, Dover JE, Nichol ST, Wilson CA (2006) Identification
of two amino acid residues on Ebola virus glycoprotein 1 critical for cell entry.
Virus Res 121: 205–214.
14. Huang Y, Xu L, Sun Y, Nabel GJ (2002) The assembly of Ebola virus
nucleocapsid requires virion-associated proteins 35 and 24 and posttranslational
modification of nucleoprotein. Mol Cell 10: 307–316.
15. Watanabe S, Noda T, Kawaoka Y (2006) Functional mapping of the
nucleoprotein of Ebola virus. J Virol 80: 3743–3751.
16. Noda T, Aoyama K, Sagara H, Kida H, Kawaoka Y (2005) Nucleocapsid-like
structures of Ebola virus reconstructed using electron tomography. J Vet Med
Sci 67: 325–328.
17. Welsch S, Kolesnikova L, Krahling V, Riches JD, Becker S, et al. (2010)
Electron tomography reveals the steps in filovirus budding. PLoS Pathog 6:
e1000875.
18. Stark H (2010) GraFix: stabilization of fragile macromolecular complexes for
single particle cryo-EM. Methods Enzymol 481: 109–126.
19. Kastner B, Fischer N, Golas MM, Sander B, Dube P, et al. (2008) GraFix:
sample preparation for single-particle electron cryomicroscopy. Nat Methods 5:
53–55.
20. Heras B, Martin JL (2005) Post-crystallization treatments for improving
diffraction quality of protein crystals. Acta Crystallogr D Biol Crystallogr 61:
1173–1180.
21. Geisbert TW, Jahrling PB (1995) Differentiation of filoviruses by electron
microscopy. Virus Res 39: 129–150.
22. Ellis DS, Stamford S, Lloyd G, Bowen ET, Platt GS, et al. (1979) Ebola and
Marburg viruses: I. Some ultrastructural differences between strains when grown
in Vero cells. J Med Virol 4: 201–211.
23. Ellis DS, Simpson IH, Francis DP, Knobloch J, Bowen ET, et al. (1978)
Ultrastructure of Ebola virus particles in human liver. J Clin Pathol 31: 201–208.
24. Siegert R, Shu HL, Slenczka W, Peters D, Muller G (1967) [On the etiology of
an unknown human infection originating from monkeys]. Dtsch Med
Wochenschr 92: 2341–2343.
25. Geisbert TW, Hensley LE, Gibb TR, Steele KE, Jaax NK, et al. (2000)
Apoptosis induced in vitro and in vivo during infection by Ebola and Marburg
viruses. Lab Invest 80: 171–186.
26. Egelman EH (2000) A robust algorithm for the reconstruction of helical
filaments using single-particle methods. Ultramicroscopy 85: 225–234.
27. Egelman EH (2007) The iterative helical real space reconstruction method:
surmounting the problems posed by real polymers. J Struct Biol 157: 83–94.
28. Noda T, Ebihara H, Muramoto Y, Fujii K, Takada A, et al. (2006) Assembly
and budding of Ebolavirus. PLoS Pathog 2: e99.
29. Noda T, Hagiwara K, Sagara H, Kawaoka Y (2010) Characterization of the
Ebola virus nucleoprotein-RNA complex. J Gen Virol 91: 1478–1483.
30. Sanchez A, Geisbert TW, Feldmann H (2007) Filoviridae: Marburg and Ebola
Viruses. In: Knipe DM, Howley PM, eds. Fields Virology. Philadelphia:
Lippincott Williams and Wilkins. pp 1409–1448.
31. Groseth A, Charton JE, Sauerborn M, Feldmann F, Jones SM, et al. (2009) The
Ebola virus ribonucleoprotein complex: a novel VP30-L interaction identified.
Virus Res 140: 8–14.
32. Tawar RG, Duquerroy S, Vonrhein C, Varela PF, Damier-Piolle L, et al. (2009)
Crystal structure of a nucleocapsid-like nucleoprotein-RNA complex of
respiratory syncytial virus. Science 326: 1279–1283.
33. Mavrakis M, Kolesnikova L, Schoehn G, Becker S, Ruigrok RW (2002)
Morphology of Marburg virus NP-RNA. Virology 296: 300–307.
34. Ellis DS, Stamford S, Tvoey DG, Lloyd G, Bowen ET, et al. (1979) Ebola and
Marburg viruses: II. Their development within Vero cells and the extra-cellular
formation of branched and torus forms. J Med Virol 4: 213–225.
35. Kallstrom G, Warfield KL, Swenson DL, Mort S, Panchal RG, et al. (2005)
Analysis of Ebola virus and VLP release using an immunocapture assay. J Virol
Methods 127: 1–9.
36. Licata JM, Johnson RF, Han Z, Harty RN (2004) Contribution of ebola virus
glycoprotein, nucleoprotein, and VP24 to budding of VP40 virus-like particles.
J Virol 78: 7344–7351.
37. Johnson RF, McCarthy SE, Godlewski PJ, Harty RN (2006) Ebola virus VP35-
VP40 interaction is sufficient for packaging 3E-5E minigenome RNA into virus-
like particles. J Virol 80: 5135–5144.
38. Elliott LH, Kiley MP, McCormick JB (1985) Descriptive analysis of Ebola virus
proteins. Virology 147: 169–176.
39. Fishbein WN (1972) Quantitative densitometry of 1–50 g protein in acrylamide
gel slabs with Coomassie blue. Anal Biochem 46: 388–401.
40. Tal M, Silberstein A, Nusser E (1985) Why does Coomassie Brilliant Blue R
interact differently with different proteins? A partial answer. J Biol Chem 260:
9976–9980.
41. Osset M, Pinol M, Fallon MJ, de Llorens R, Cuchillo CM (1989) Interference of
the carbohydrate moiety in coomassie brilliant blue R-250 protein staining.
Electrophoresis 10: 271–273.
42. Lee JE, Fusco ML, Hessell AJ, Oswald WB, Burton DR, et al. (2008) Structure
of the Ebola virus glycoprotein bound to an antibody from a human survivor.
Nature 454: 177–182.
43. Hood CL, Abraham J, Boyington JC, Leung K, Kwong PD, et al. (2010)
Biochemical and structural characterization of cathepsin L-processed Ebola
virus glycoprotein: implications for viral entry and immunogenicity. J Virol 84:
2972–2982.
44. Beniac DR, Andonov A, Grudeski E, Booth TF (2006) Architecture of the SARS
coronavirus prefusion spike. Nat Struct Mol Biol 13: 751–752.
45. Wriggers W, Birmanns S (2001) Using situs for flexible and rigid-body fitting of
multiresolution single-molecule data. J Struct Biol 133: 193–202.
46. Chandran K, Sullivan NJ, Felbor U, Whelan SP, Cunningham JM (2005)
Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection.
Science 308: 1643–1645.
47. Kaletsky RL, Simmons G, Bates P (2007) Proteolysis of the Ebola virus
glycoproteins enhances virus binding and infectivity. J Virol 81: 13378–13384.
48. Shedlock DJ, Bailey MA, Popernack PM, Cunningham JM, Burton DR, et al.
(2010) Antibody-mediated neutralization of Ebola virus can occur by two distinct
mechanisms. Virology 401: 228–235.
49. Calder LJ, Wasilewski S, Berriman JA, Rosenthal PB (2010) Structural
organization of a filamentous influenza A virus. Proc Natl Acad Sci U S A
107: 10685–10690.
50. Halfmann P, Ebihara H, Marzi A, Hatta Y, Watanabe S, et al. (2009)
Replication-deficient ebolavirus as a vaccine candidate. J Virol 83: 3810–3815.
51. Melito PL, Qiu X, Fernando LM, Devarennes SL, Beniac DR, et al. (2008) The
creation of stable cell lines expressing Ebola virus glycoproteins and the matrix
protein VP40 and generating Ebola virus-like particles utilizing an ecdysone
inducible mammalian expression system. J Virol Methods 148: 237–243.
52. Abramoff MD, Magelhaes PJ, Ram SJ (2004) Image Processing with ImageJ.
Biophotonics International 11: 36–42.
53. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, et al.
(2004) UCSF Chimera–a visualization system for exploratory research and
analysis. J Comput Chem 25: 1605–1612.
54. Ludtke SJ, Baldwin PR, Chiu W (1999) EMAN: semiautomated software for
high-resolution single-particle reconstructions. J Struct Biol 128: 82–97.
55. Frank J, Radermacher M, Penczek P, Zhu J, Li Y, et al. (1996) SPIDER and
WEB: processing and visualization of images in 3D electron microscopy and
related fields. J Struct Biol 116: 190–199.
56. Beniac DR, Devarennes SL, Andonov A, He R, Booth TF (2007)
Conformational Reorganization of the SARS Coronavirus Spike Following
Receptor Binding: Implications for Membrane Fusion. PLoS ONE 2: e1082.
57. Wriggers W, Milligan RA, McCammon JA (1999) Situs: A package for docking
crystal structures into low-resolution maps from electron microscopy. J Struct
Biol 125: 185–195.
58. Green TJ, Zhang X, Wertz GW, Luo M (2006) Structure of the vesicular
stomatitis virus nucleoprotein-RNA complex. Science 313: 357–360.
Organisation of Ebola Virus
PLoS ONE | www.plosone.org 12 January 2012 | Volume 7 | Issue 1 | e29608